Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 10.20
0.00 (0.00%)
At close: Dec 5, 2025
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 696.27 million as of December 5, 2025. Its market cap has increased by 134.70% in one year.
Market Cap
696.27M
Enterprise Value
608.70M
Revenue
377.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.20
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 696.27M, a decrease of -3.37%. That is a compound annual growth rate of -0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 696.27M | 73.47% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.70B |
| Nordhealth AS | 2.69B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.54B |
| ArcticZymes Technologies ASA | 1.08B |
| Omda AS | 953.61M |
| Vistin Pharma ASA | 873.59M |
| Gentian Diagnostics ASA | 842.06M |